Medline Industries   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Mundelein IL United States (1966)
Status: No NME R&D (1966)

Organization Overview

First Clinical Trial
2014
NCT02530528
First Marketed Drug
2018
chlorhexidine (hibitane)
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Medline Industries | MEDLINE INDUSTRIES

Active Ingredients

Marketed Drugs (1)

chlorhexidine (hibitane) (2018)

Drugs in Phase 4 Trials (1)

ethanol (1 trial)

Drugs in Phase 3 Trials (4)

Key: Medline Industries (3) Acquired (1)

chlorhexidine (hibitane) (9 trials)

icosapent ethyl (vascepa) (1 trial)

iloperidone (fanapt) (1 trial)

sodium chloride (1 trial)

Drugs in Phase 2 Trials (2)

Key: Medline Industries (1) Acquired (1)

ex039 (1 trial)

surfactant (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial APIs: 7